Inventiva S.A. (IVEVF) Financials

IVEVF Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 286.3 million 219.0 million
March 31, 2026 285.9 million 318.6 million
Dec. 31, 2025 292.9 million 326.4 million
June 30, 2025 210.9 million 221.4 million

IVEVF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -66.0 million ?
March 31, 2026 -58.9 million ?
Dec. 31, 2025 -60.4 million ?
June 30, 2025 -63.4 million 9.4 million

IVEVF Net Income

No data available :(

IVEVF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 189.3 million 60.8 million -
March 31, 2026 264.6 million - -
Dec. 31, 2025 271.0 million 31.5 million 3.3 million
June 30, 2025 172.9 million 60.8 million 4.7 million

IVEVF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 312.2 million
March 31, 2026 730.1 million
Dec. 31, 2025 747.9 million
June 30, 2025 128.3 million

IVEVF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 190245 52.4 million 28.1 million -
March 31, 2026 217650 49.6 million 41.1 million 4.7 million
Dec. 31, 2025 222968 50.8 million 45.4 million 4.8 million
June 30, 2025 67183 52.9 million 17.9 million 869852

IVEVF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 22647 1.6 million
March 31, 2026 33219 1.4 million
Dec. 31, 2025 34030 1.4 million
June 30, 2025 6.6 million 63647

IVEVF

Price: $3.18

52 week price:
2.28
5.75

Earnings Per Share: -0.60 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 760.6 million

Links: